» Articles » PMID: 30994234

Clinical Usefulness of Magnifying Colonoscopy for the Diagnosis of Ulcerative Colitis-associated Neoplasia

Overview
Journal Dig Endosc
Date 2019 Apr 18
PMID 30994234
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Background And Aim: The aim of this investigation was to evaluate the efficacy of Japanese magnifying colonoscopic classifications for ulcerative colitis-associated neoplasia (UCAN).

Methods: We reviewed the colonoscopy records from 2011 to 2018 at our institutions and identified cases of endoscopically or surgically resected UCAN observed by magnifying narrow-band imaging (NBI) endoscopy and magnifying chromoendoscopy. Association between magnifying endoscopic classification and histopathological findings was investigated retrospectively. Japan NBI expert team (JNET) classification and pit pattern classification were applied.

Results: There were 17 patients who had a diagnosis of UCAN. Tumors of types 2A, 2B and 3 by JNET classification correlated with the histopathological findings of low-grade dysplasia (LGD)/high-grade dysplasia (HGD), HGD, and massively submucosal invasive (mSM) carcinoma, respectively. Tumors of types III/IV, V low irregularity, and V high irregularity/V by pit pattern classification were correlated with the histopathological findings of LGD/HGD, HGD, and mSM carcinoma, respectively.

Conclusions: Japan NBI expert team classification and pit pattern classification may be predictive of the histological diagnosis and invasion depth of UCAN. This needs to be investigated prospectively in a large cohort or in a randomized clinical trial.

Citing Articles

Colitis-Associated Dysplasia in Inflammatory Bowel Disease: Features and Endoscopic Management.

Schiavone S, Biancone L, Fiorillo M, Divizia A, Mancone R, Neri B Cancers (Basel). 2025; 17(5).

PMID: 40075631 PMC: 11899620. DOI: 10.3390/cancers17050784.


Advancements in Endoscopic Resection for Colitis-Associated Colorectal Neoplasia in Inflammatory Bowel Disease: Turning Visible into Resectable.

Maselli R, De Sire R, Massimi D, Franchellucci G, Busacca A, Castiglione F Diagnostics (Basel). 2024; 14(1).

PMID: 38201318 PMC: 10795709. DOI: 10.3390/diagnostics14010009.


Endoscopic characterization of neoplastic and non-neoplastic lesions in inflammatory bowel disease: systematic review in the era of advanced endoscopic imaging.

Cassinotti A, Parravicini M, Chapman T, Balzarini M, Canova L, Segato S Therap Adv Gastroenterol. 2023; 16:17562848231208667.

PMID: 37954537 PMC: 10638882. DOI: 10.1177/17562848231208667.


New endoscopic tools in inflammatory bowel disease.

Nardone O, Cannatelli R, Ghosh S, Iacucci M United European Gastroenterol J. 2022; 10(10):1103-1112.

PMID: 36225117 PMC: 9752280. DOI: 10.1002/ueg2.12316.


Endoscopic Surveillance in Inflammatory Bowel Diseases: Selecting a Suitable Technology.

Dal Buono A, Gabbiadini R, Furfaro F, Argollo M, Trigo T, Repici A Front Med (Lausanne). 2022; 9:855652.

PMID: 35433767 PMC: 9005849. DOI: 10.3389/fmed.2022.855652.